Cardiac nitric oxide synthases are elevated in dietary copper deficiency

Journal of Nutritional Biochemistry

Volumn 18, Issue 7, 2007, Pages 443-448

  Saari, Jack T ^a   Wold, Loren E ^b   Duan, Jinhong ^b   Ren, Jun ^b   Carlson, Hanqian L ^b   Bode, Ann M ^c   Lentsch, Alex B ^d   Zeng, Huawei ^a   Schuschke, Dale A ^e  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e University of Louisville School of Medicine   (United States)

Author keywords

Copper deficiency; eNOS; Heart; iNOS; NF B; Nitric oxide synthase

Indexed keywords

COPPER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; IRON; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART FUNCTION; HEART PROTECTION; HEART WEIGHT; HEMATOCRIT; MALE; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ARGININE; CITRULLINE; COPPER; DIET; MALE; MODELS, ANIMAL; MYOCARDIUM; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34249893355     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.07.006     Document Type: Article

References (46)

1. Medeiros D.M., and Wildman R.E.C. Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc Soc Exp Biol Med 215 (1997) 299-313
2. Redman R.S., Fields M., Reiser S., and Smith Jr. J.C. Dietary fructose exacerbates the cardiac abnormalities of copper deficiency in rats. Atherosclerosis 74 (1988) 203-214
3. Allen C.B., and Saari J.T. Isolated hearts from copper-deficient rats exhibit improved postischemic contractile performance. J Nutr 123 (1993) 1794-1800
4. Prohaska J.R., and Heller L.J. Mechanical properties of the copper-deficient rat heart. J Nutr 112 (1982) 2142-2150
5. Klevay L.M., and Viestenz K.E. Abnormal electrocardiograms in rats deficient in copper. Am J Physiol 240 (1981) H185-H189
6. Jenkins J.E., and Medeiros D.M. Diets containing corn oil, coconut oil and cholesterol alter ventricular hypertrophy, dilatation and function in hearts of rats fed copper-deficient diets. J Nutr 123 (1993) 1150-1160
7. Kang Y.J., Zhou Z.X., Wu H., Wang G.W., Saari J.T., and Klein J.B. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80 (2000) 745-757
8. Kang Y.J., Wu H., and Saari J.T. Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart. Proc Soc Exp Biol Med 223 (2000) 282-287
9. Elsherif L., Ortines R.V., Saari J.T., and Kang Y.J. Congestive heart failure in copper-deficient mice. Exp Biol Med 228 (2003) 811-817
10. Elsherif L., Wang L., Saari J.T., and Kang Y.J. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J Nutr 134 (2004) 855-860
11. Elsherif L., Jiang Y., Saari J.T., and Kang Y.J. Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion. Exp Biol Med 229 (2004) 616-622
12. Chien K.R. Stress pathways and heart failure. Cell 98 (1999) 555-558
13. Depre C., Tomlinson J.E., Kudej R.K., Gaussin V., Thompson E., Kim S.J., et al. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs. Proc Natl Acad Sci USA 98 (2001) 9336-9341
14. Kim Y.-M., Bombeck C.A., and Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84 (1999) 253-256
15. Nandagopal K., Dawson T.M., and Dawson V.L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 297 (2001) 474-478
16. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
17. Dawn B., and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann NY Acad Sci 962 (2002) 18-41
18. Uriu-Adams J.Y., and Keen C.L. Copper, oxidative stress, and human health. Mol Aspects Med 26 (2005) 268-298
19. Saari J.T. Copper deficiency and cardiovascular disease: role of peroxidation, glycation and nitration. Can J Physiol Pharmacol 78 (2000) 848-855
20. Saari J.T., and Dahlen G.M. Nitric oxide and cyclic GMP are elevated in the hearts of copper-deficient rats. Med Sci Res 26 (1998) 495-497
21. Saari J.T., and Bode A.M. Expression of inducible nitric oxide synthase is elevated in hearts of copper-deficient rats. FASEB J 13 (1999) A371
22. Ren J., Walsh M.F., Hamaty M., Sowers J.R., and Brown R.A. Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO. Am J Physiol 275 (1998) H823-H830
23. Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86 (1989) 9030-9033
24. Schell D.A., Murphy T.C., and Samson W.K. Endothelin modulation of prolactin secretion. Front Endocrinol 15 (1995) 145-151
25. Nickola M.W., Wold L.E., Colligan P.B., Wang G.J., Samson W.K., and Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes: role of NO. Hypertension 36 (2000) 501-505
26. Klevay L.M., and Saari J.T. Comparative responses of rats to different copper intakes and modes of supplementation. Proc Soc Exp Biol Med 203 (1993) 214-220
27. Kinugawa K.I., Shimizu T., Yao A., Kohmoto O., Serizawa T., and Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 81 (1997) 911-921
28. Failla M.L. Trace elements and host defense: recent advances and continuing challenges. J Nutr 133 (2003) 1443S-1447S
29. Satake H., Suzuki K., Aoki T., Otsuka M., Sugiura Y., Yamamoto T., et al. Cupric ion blocks NFκB activation through inhibiting the signal-induced phosphorylation of IκBα. Biochem Biophys Res Commun 216 (1995) 568-573
30. Pan Q., Kleer C.G., van Golen K.L., Irani J., Bottema K.M., Bias C., et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 62 (2002) 4854-4859
31. Maziere C., Auclair M., Djavaheri-Mergny M., Packer L., and Maziere J.C. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells. Biochem Mol Biol Int 39 (1996) 1201-1207
32. Ricklefs K., Klaahsen D.L., and Medeiros D.M. Copper deficiency and mitochondrial biogenesis: the role of transcriptional factors PPAR-alpha, PGC-1 alpha and NFkb1. FASEB J 20 (2006) A553
33. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol Regul Integr Comp Physiol 274 (1998) R577-R595
34. Morgan E.N., Boyle Jr. E.M., Yun W., Griscavage-Ennis J.M., Farr A.L., Canty Jr. T.G., et al. An essential role for NF-kB in the cardioadaptive response to ischemia. Ann Thorac Surg 68 (1999) 377-382
35. Wollert K.C., and Drexler H. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev 7 (2002) 317-325
36. Schuschke D.A., Falcone J.C., Saari J.T., Fleming J.T., Percival S.S., Young S.A., et al. Endothelial cell calcium mobilization to acetylcholine is attenuated in copper-deficient rats. Endothelium 7 (2000) 83-92
37. Beckers-Trapp M.E., Lanoue L., Keen C.L., Rucker R.B., and Uriu-Adams J.Y. Abnormal development and increased 3-nitrotyrosine in copper-deficient mouse embryos. Free Radic Biol Med 40 (2006) 35-44
38. Holbrook N.J., and Ikeyama S. Age-related decline in cellular response to oxidative stress: links to growth factor signaling pathways with common defects. Biochem Pharmacol 64 (2002) 999-1005
39. Cai Z., Manalo D.J., Wei G., Rodriguez E.R., Fox-Talbot K., Lu H., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108 (2003) 79-85
40. Gao F., Gao E., Yue T.-L., Ohlstein E.H., Lopez B.L., Christopher T.A., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105 (2002) 1497-1502
41. Kelly R.A., Balligand J.L., and Smith T.W. Nitric oxide and cardiac function. Circ Res 79 (1996) 363-380
42. Franke T.F., Kaplan D.R., and Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 88 (1997) 435-437
43. Wang Y., Ahmad N., Kudo M., and Ashraf M. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am J Physiol Heart Circ Physiol 287 (2004) H1125-H1131
44. Lochner A., Marais E., Genade S., and Moolman J.A. Nitric oxide: a trigger for classic preconditioning?. Am J Physiol Heart Circ Physiol 279 (2000) H2752-H2765
45. Bolli R., Dawn B., Tang X.L., Qiu Y., Ping P., Xuan Y.T., et al. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93 (1998) 325-338
46. Dong F., Esberg L.B., Roughead Z.K., Ren J., and Saari J.T. Increased contractility of cardiomyocytes from copper-deficient rats is associated with up-regulation of the cardiac insulin-like growth factor-I receptor. Am J Physiol Heart Circ Physiol 289 (2005) H78-H84